Development of a Novel Perfusion Technique to Allow Targeted Delivery of Gene Therapy-The V-Focus System
J Extra Corpor Technol, 38 1 (2006) 51-52
Published online: 2006-03-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Cardiac gene therapy: are we there yet?
P N Matkar, H Leong-Poi and K K SinghGene Therapy 23 (8-9) 635 (2016)
https://doi.org/10.1038/gt.2016.43
Cardiac gene therapy with SERCA2a: From bench to bedside
Judith K. Gwathmey, Alexan I. Yerevanian and Roger J. HajjarJournal of Molecular and Cellular Cardiology 50 (5) 803 (2011)
https://doi.org/10.1016/j.yjmcc.2010.11.011
709 355 (2011)
https://doi.org/10.1007/978-1-61737-982-6_23
Cardiac Gene Therapy
Antoine H. Chaanine, Jill Kalman and Roger J. HajjarSeminars in Thoracic and Cardiovascular Surgery 22 (2) 127 (2010)
https://doi.org/10.1053/j.semtcvs.2010.09.009
Gene therapy for heart failure
Mario T. Njeim and Roger J. HajjarArchives of Cardiovascular Diseases 103 (8-9) 477 (2010)
https://doi.org/10.1016/j.acvd.2010.04.004
Sarcoplasmic reticulum Ca2+ATPase as a therapeutic target for heart failure
Larissa Lipskaia, Elie R Chemaly, Lahouaria Hadri, Anne-Marie Lompre and Roger J HajjarExpert Opinion on Biological Therapy 10 (1) 29 (2010)
https://doi.org/10.1517/14712590903321462
Gene and Cell Therapy for Heart Failure
Ebo D. de MuinckAntioxidants & Redox Signaling 11 (8) 2025 (2009)
https://doi.org/10.1089/ars.2009.2495
Reversing Advanced Heart Failure by Targeting Ca2+ Cycling
David M. Kaye, Masahiko Hoshijima and Kenneth R. ChienAnnual Review of Medicine 59 (1) 13 (2008)
https://doi.org/10.1146/annurev.med.59.052407.103237
Advances in Gene-Based Therapy for Heart Failure
Hung Q. Ly, Yoshiaki Kawase and Roger J. HajjarJournal of Cardiovascular Translational Research 1 (2) 127 (2008)
https://doi.org/10.1007/s12265-008-9022-4
Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
Roger J. Hajjar, Krisztina Zsebo, Lawrence Deckelbaum, Craig Thompson, Jeff Rudy, Alex Yaroshinsky, Hung Ly, Yoshiaki Kawase, Kim Wagner, Kenneth Borow, Brian Jaski, Barry London, Barry Greenberg, Daniel F. Pauly, Richard Patten, Randall Starling, Donna Mancini and Mariell JessupJournal of Cardiac Failure 14 (5) 355 (2008)
https://doi.org/10.1016/j.cardfail.2008.02.005
Treatment of Heart Failure by Calcium Cycling Gene Therapy
Larissa Lipskaia, Hung Ly, Yoshiaki Kawase, Roger J Hajjar and Anne-Marie LompreFuture Cardiology 3 (4) 413 (2007)
https://doi.org/10.2217/14796678.3.4.413
AAV vectors and cardiovascular disease: Targeting TNF receptor in the heart: clue to way forward with AAV?
R J Hajjar and K ZseboGene Therapy 14 (23) 1611 (2007)
https://doi.org/10.1038/sj.gt.3303047